Medical Care

Transcriptome Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics.
The global market for Transcriptome Technology was estimated to be worth US$ 3515 million in 2023 and is forecast to a readjusted size of US$ 6850.6 million by 2030 with a CAGR of 10.0% during the forecast period 2024-2030
North American market for Transcriptome Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Transcriptome Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Transcriptome Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Transcriptome Technology include Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories and Fluidigm, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transcriptome Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Transcriptome Technology by region & country, by Type, and by Application.
The Transcriptome Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcriptome Technology.
Market Segmentation
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type:
PCR
Microarray
Sequencing
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Transcriptome Technology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Transcriptome Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Transcriptome Technology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Transcriptome Technology Product Introduction
1.2 Global Transcriptome Technology Market Size Forecast
1.3 Transcriptome Technology Market Trends & Drivers
1.3.1 Transcriptome Technology Industry Trends
1.3.2 Transcriptome Technology Market Drivers & Opportunity
1.3.3 Transcriptome Technology Market Challenges
1.3.4 Transcriptome Technology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Transcriptome Technology Players Revenue Ranking (2023)
2.2 Global Transcriptome Technology Revenue by Company (2019-2024)
2.3 Key Companies Transcriptome Technology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Transcriptome Technology Product Offered
2.5 Key Companies Time to Begin Mass Production of Transcriptome Technology
2.6 Transcriptome Technology Market Competitive Analysis
2.6.1 Transcriptome Technology Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Transcriptome Technology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcriptome Technology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 PCR
3.1.2 Microarray
3.1.3 Sequencing
3.2 Global Transcriptome Technology Sales Value by Type
3.2.1 Global Transcriptome Technology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Transcriptome Technology Sales Value, by Type (2019-2030)
3.2.3 Global Transcriptome Technology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical and Biotechnology
4.1.2 Academic Research and Government Institutes
4.1.3 Hospitals and Diagnostic Centers
4.2 Global Transcriptome Technology Sales Value by Application
4.2.1 Global Transcriptome Technology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Transcriptome Technology Sales Value, by Application (2019-2030)
4.2.3 Global Transcriptome Technology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Transcriptome Technology Sales Value by Region
5.1.1 Global Transcriptome Technology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Transcriptome Technology Sales Value by Region (2019-2024)
5.1.3 Global Transcriptome Technology Sales Value by Region (2025-2030)
5.1.4 Global Transcriptome Technology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Transcriptome Technology Sales Value, 2019-2030
5.2.2 North America Transcriptome Technology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Transcriptome Technology Sales Value, 2019-2030
5.3.2 Europe Transcriptome Technology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Transcriptome Technology Sales Value, 2019-2030
5.4.2 Asia Pacific Transcriptome Technology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Transcriptome Technology Sales Value, 2019-2030
5.5.2 South America Transcriptome Technology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Transcriptome Technology Sales Value, 2019-2030
5.6.2 Middle East & Africa Transcriptome Technology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Transcriptome Technology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Transcriptome Technology Sales Value
6.3 United States
6.3.1 United States Transcriptome Technology Sales Value, 2019-2030
6.3.2 United States Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Transcriptome Technology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Transcriptome Technology Sales Value, 2019-2030
6.4.2 Europe Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Transcriptome Technology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Transcriptome Technology Sales Value, 2019-2030
6.5.2 China Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
6.5.3 China Transcriptome Technology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Transcriptome Technology Sales Value, 2019-2030
6.6.2 Japan Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Transcriptome Technology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Transcriptome Technology Sales Value, 2019-2030
6.7.2 South Korea Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Transcriptome Technology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Transcriptome Technology Sales Value, 2019-2030
6.8.2 Southeast Asia Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Transcriptome Technology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Transcriptome Technology Sales Value, 2019-2030
6.9.2 India Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
6.9.3 India Transcriptome Technology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific Transcriptome Technology Products, Services and Solutions
7.1.4 Thermo Fisher Scientific Transcriptome Technology Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Illumina
7.2.1 Illumina Profile
7.2.2 Illumina Main Business
7.2.3 Illumina Transcriptome Technology Products, Services and Solutions
7.2.4 Illumina Transcriptome Technology Revenue (US$ Million) & (2019-2024)
7.2.5 Illumina Recent Developments
7.3 QIAGEN (Exiqon)
7.3.1 QIAGEN (Exiqon) Profile
7.3.2 QIAGEN (Exiqon) Main Business
7.3.3 QIAGEN (Exiqon) Transcriptome Technology Products, Services and Solutions
7.3.4 QIAGEN (Exiqon) Transcriptome Technology Revenue (US$ Million) & (2019-2024)
7.3.5 Agilent Technologies Recent Developments
7.4 Agilent Technologies
7.4.1 Agilent Technologies Profile
7.4.2 Agilent Technologies Main Business
7.4.3 Agilent Technologies Transcriptome Technology Products, Services and Solutions
7.4.4 Agilent Technologies Transcriptome Technology Revenue (US$ Million) & (2019-2024)
7.4.5 Agilent Technologies Recent Developments
7.5 Roche
7.5.1 Roche Profile
7.5.2 Roche Main Business
7.5.3 Roche Transcriptome Technology Products, Services and Solutions
7.5.4 Roche Transcriptome Technology Revenue (US$ Million) & (2019-2024)
7.5.5 Roche Recent Developments
7.6 GE Healthcare
7.6.1 GE Healthcare Profile
7.6.2 GE Healthcare Main Business
7.6.3 GE Healthcare Transcriptome Technology Products, Services and Solutions
7.6.4 GE Healthcare Transcriptome Technology Revenue (US$ Million) & (2019-2024)
7.6.5 GE Healthcare Recent Developments
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Profile
7.7.2 Bio-Rad Laboratories Main Business
7.7.3 Bio-Rad Laboratories Transcriptome Technology Products, Services and Solutions
7.7.4 Bio-Rad Laboratories Transcriptome Technology Revenue (US$ Million) & (2019-2024)
7.7.5 Bio-Rad Laboratories Recent Developments
7.8 Fluidigm
7.8.1 Fluidigm Profile
7.8.2 Fluidigm Main Business
7.8.3 Fluidigm Transcriptome Technology Products, Services and Solutions
7.8.4 Fluidigm Transcriptome Technology Revenue (US$ Million) & (2019-2024)
7.8.5 Fluidigm Recent Developments
8 Industry Chain Analysis
8.1 Transcriptome Technology Industrial Chain
8.2 Transcriptome Technology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Transcriptome Technology Sales Model
8.5.2 Sales Channel
8.5.3 Transcriptome Technology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Transcriptome Technology Market Trends
Table 2. Transcriptome Technology Market Drivers & Opportunity
Table 3. Transcriptome Technology Market Challenges
Table 4. Transcriptome Technology Market Restraints
Table 5. Global Transcriptome Technology Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Transcriptome Technology Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Transcriptome Technology Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Transcriptome Technology Product Type
Table 9. Key Companies Time to Begin Mass Production of Transcriptome Technology
Table 10. Global Transcriptome Technology Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcriptome Technology as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Transcriptome Technology Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Transcriptome Technology Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Transcriptome Technology Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Transcriptome Technology Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Transcriptome Technology Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Transcriptome Technology Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Transcriptome Technology Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Transcriptome Technology Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Transcriptome Technology Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Transcriptome Technology Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Transcriptome Technology Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Transcriptome Technology Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Transcriptome Technology Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Transcriptome Technology Sales Value by Region (2019-2024) & (%)
Table 27. Global Transcriptome Technology Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Transcriptome Technology Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Transcriptome Technology Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Transcriptome Technology Sales Value, (2025-2030) & (US$ Million)
Table 31. Thermo Fisher Scientific Basic Information List
Table 32. Thermo Fisher Scientific Description and Business Overview
Table 33. Thermo Fisher Scientific Transcriptome Technology Products, Services and Solutions
Table 34. Revenue (US$ Million) in Transcriptome Technology Business of Thermo Fisher Scientific (2019-2024)
Table 35. Thermo Fisher Scientific Recent Developments
Table 36. Illumina Basic Information List
Table 37. Illumina Description and Business Overview
Table 38. Illumina Transcriptome Technology Products, Services and Solutions
Table 39. Revenue (US$ Million) in Transcriptome Technology Business of Illumina (2019-2024)
Table 40. Illumina Recent Developments
Table 41. QIAGEN (Exiqon) Basic Information List
Table 42. QIAGEN (Exiqon) Description and Business Overview
Table 43. QIAGEN (Exiqon) Transcriptome Technology Products, Services and Solutions
Table 44. Revenue (US$ Million) in Transcriptome Technology Business of QIAGEN (Exiqon) (2019-2024)
Table 45. QIAGEN (Exiqon) Recent Developments
Table 46. Agilent Technologies Basic Information List
Table 47. Agilent Technologies Description and Business Overview
Table 48. Agilent Technologies Transcriptome Technology Products, Services and Solutions
Table 49. Revenue (US$ Million) in Transcriptome Technology Business of Agilent Technologies (2019-2024)
Table 50. Agilent Technologies Recent Developments
Table 51. Roche Basic Information List
Table 52. Roche Description and Business Overview
Table 53. Roche Transcriptome Technology Products, Services and Solutions
Table 54. Revenue (US$ Million) in Transcriptome Technology Business of Roche (2019-2024)
Table 55. Roche Recent Developments
Table 56. GE Healthcare Basic Information List
Table 57. GE Healthcare Description and Business Overview
Table 58. GE Healthcare Transcriptome Technology Products, Services and Solutions
Table 59. Revenue (US$ Million) in Transcriptome Technology Business of GE Healthcare (2019-2024)
Table 60. GE Healthcare Recent Developments
Table 61. Bio-Rad Laboratories Basic Information List
Table 62. Bio-Rad Laboratories Description and Business Overview
Table 63. Bio-Rad Laboratories Transcriptome Technology Products, Services and Solutions
Table 64. Revenue (US$ Million) in Transcriptome Technology Business of Bio-Rad Laboratories (2019-2024)
Table 65. Bio-Rad Laboratories Recent Developments
Table 66. Fluidigm Basic Information List
Table 67. Fluidigm Description and Business Overview
Table 68. Fluidigm Transcriptome Technology Products, Services and Solutions
Table 69. Revenue (US$ Million) in Transcriptome Technology Business of Fluidigm (2019-2024)
Table 70. Fluidigm Recent Developments
Table 71. Key Raw Materials Lists
Table 72. Raw Materials Key Suppliers Lists
Table 73. Transcriptome Technology Downstream Customers
Table 74. Transcriptome Technology Distributors List
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
Table 78. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Transcriptome Technology Product Picture
Figure 2. Global Transcriptome Technology Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Transcriptome Technology Sales Value (2019-2030) & (US$ Million)
Figure 4. Transcriptome Technology Report Years Considered
Figure 5. Global Transcriptome Technology Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Transcriptome Technology Revenue in 2023
Figure 7. Transcriptome Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. PCR Picture
Figure 9. Microarray Picture
Figure 10. Sequencing Picture
Figure 11. Global Transcriptome Technology Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Transcriptome Technology Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Pharmaceutical and Biotechnology
Figure 14. Product Picture of Academic Research and Government Institutes
Figure 15. Product Picture of Hospitals and Diagnostic Centers
Figure 16. Global Transcriptome Technology Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Transcriptome Technology Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Transcriptome Technology Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Transcriptome Technology Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Transcriptome Technology Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Transcriptome Technology Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Transcriptome Technology Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Transcriptome Technology Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Transcriptome Technology Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Transcriptome Technology Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Transcriptome Technology Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Transcriptome Technology Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Transcriptome Technology Sales Value (%), (2019-2030)
Figure 29. United States Transcriptome Technology Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Transcriptome Technology Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Transcriptome Technology Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Transcriptome Technology Sales Value by Application (%), 2023 VS 2030
Figure 35. China Transcriptome Technology Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
Figure 37. China Transcriptome Technology Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Transcriptome Technology Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Transcriptome Technology Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Transcriptome Technology Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Transcriptome Technology Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Transcriptome Technology Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Transcriptome Technology Sales Value by Application (%), 2023 VS 2030
Figure 47. India Transcriptome Technology Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
Figure 49. India Transcriptome Technology Sales Value by Application (%), 2023 VS 2030
Figure 50. Transcriptome Technology Industrial Chain
Figure 51. Transcriptome Technology Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies